2013
DOI: 10.1016/j.cct.2013.08.006
|View full text |Cite
|
Sign up to set email alerts
|

The Cooperative Lifestyle Intervention Program-II (CLIP-II): Design and methods

Abstract: A complication of cardiovascular disease (CVD) and the metabolic syndrome (MetS) among older adults is loss of mobility. The American Heart Association has identified weight management as a core component of secondary prevention programs for CVD and is an important risk factor for physical disability. The American Society for Nutrition and the Obesity Society have highlighted the need for long-term randomized clinical trials to evaluate the independent and additive effects of diet-induced weight loss (WL) and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
30
0
1

Year Published

2016
2016
2019
2019

Publication Types

Select...
6

Relationship

5
1

Authors

Journals

citations
Cited by 25 publications
(31 citation statements)
references
References 109 publications
(106 reference statements)
0
30
0
1
Order By: Relevance
“…Details of recruitment and baseline characteristics were published previously. 12 The mean age AE SD of included participants was 78.9 AE 5.2, 67.2% were women, 23.6% were racial or ethnic minorities, 35.9% were married, and 63.8% reported having a college education. In general, participants were cognitively intact (modified Mini-Mental State Examination score 91.7 AE 5.4), showed low levels of depressive symptoms (Center for Epidemiologic Studies Depression Scale score 8.5 AE 7.8), and had relatively poor sleep quality (Pittsburgh Sleep Quality Index score 5.9 AE 3.8).…”
Section: Resultsmentioning
confidence: 96%
See 1 more Smart Citation
“…Details of recruitment and baseline characteristics were published previously. 12 The mean age AE SD of included participants was 78.9 AE 5.2, 67.2% were women, 23.6% were racial or ethnic minorities, 35.9% were married, and 63.8% reported having a college education. In general, participants were cognitively intact (modified Mini-Mental State Examination score 91.7 AE 5.4), showed low levels of depressive symptoms (Center for Epidemiologic Studies Depression Scale score 8.5 AE 7.8), and had relatively poor sleep quality (Pittsburgh Sleep Quality Index score 5.9 AE 3.8).…”
Section: Resultsmentioning
confidence: 96%
“…Details of recruitment and baseline characteristics were published previously . The mean age ± SD of included participants was 78.9 ± 5.2, 67.2% were women, 23.6% were racial or ethnic minorities, 35.9% were married, and 63.8% reported having a college education.…”
Section: Resultsmentioning
confidence: 99%
“…Because these data come from an RCT of exercise and weight loss in older adults , treatment effects on mobility , body composition , and bone outcomes have been previously reported. Briefly, regarding body composition, significant reductions in total fat mass and total lean mass were observed in all groups over the 18‐month intervention period, with resistance exercise able to attenuate lean mass loss compared with aerobic exercise (−0.8 [SD 0.3] kg, −1.5% vs. −1.0 [SD 0.3] kg, −2.0%), and weight loss combined with either exercise modality augmented fat mass loss compared with weight loss alone (WL+AT: −6.8 [SD 0.6] kg, −16.4% and WL+RT: −7.8 [SD 0.5] kg, −19.0% vs. WL: −4.8 [SD 0.6] kg, −10.9%) .…”
Section: Resultsmentioning
confidence: 99%
“…Because these data come from an RCT of exercise and weight loss in older adults (25), treatment effects on mobility (26), body composition (27), and bone outcomes (28) have been previously reported. Briefly, regarding body composition, significant reductions in total fat mass and total lean mass were observed in all groups over the 18-month intervention period, with resistance exercise able to attenuate lean mass loss compared with aerobic exercise (−0.…”
Section: Intervention Effects On Fat Mass Lean Mass and Bone Massmentioning
confidence: 99%
“…In accordance with international recommendations, (35) bone formation marker Procollagen Type 1 N-Terminal Propeptide (P1NP), and bone resorption marker C-Terminal Telopeptide of Type 1 Collagen (CTX) were performed using commercially available ELISAs (NeoScientific, Cambridge, MA), as done previously. (39) …”
Section: Methodsmentioning
confidence: 99%